Altered infective competence of the human gut microbiome in COVID-19

in Microbiome (2023), 11(1), 46

BACKGROUND: Infections with SARS-CoV-2 have a pronounced impact on the gastrointestinal tract and its resident microbiome. Clear differences between severe cases of infection and healthy individuals have ... [more ▼]

BACKGROUND: Infections with SARS-CoV-2 have a pronounced impact on the gastrointestinal tract and its resident microbiome. Clear differences between severe cases of infection and healthy individuals have been reported, including the loss of commensal taxa. We aimed to understand if microbiome alterations including functional shifts are unique to severe cases or a common effect of COVID-19. We used high-resolution systematic multi-omic analyses to profile the gut microbiome in asymptomatic-to-moderate COVID-19 individuals compared to a control group. RESULTS: We found a striking increase in the overall abundance and expression of both virulence factors and antimicrobial resistance genes in COVID-19. Importantly, these genes are encoded and expressed by commensal taxa from families such as Acidaminococcaceae and Erysipelatoclostridiaceae, which we found to be enriched in COVID-19-positive individuals. We also found an enrichment in the expression of a betaherpesvirus and rotavirus C genes in COVID-19-positive individuals compared to healthy controls. CONCLUSIONS: Our analyses identified an altered and increased infective competence of the gut microbiome in COVID-19 patients. Video Abstract. [less ▲]

Individual factors and beliefs determining COVID-19 vaccination willingness

Poster (2022, April)

Background: High vaccination coverage rates are necessary to reduce infections and transmissions of the SARS-CoV-2 virus causing COVID-19 and to allow successful mitigation of the current pandemic. To ... [more ▼]

Background: High vaccination coverage rates are necessary to reduce infections and transmissions of the SARS-CoV-2 virus causing COVID-19 and to allow successful mitigation of the current pandemic. To date, we are still lacking information to explain the hesitancy in Luxembourg towards uptake of the available COVID-19 vaccines. The present study explored motivations for and against vaccination in a population-representative sample of residents across Luxembourg to identify hesitant groups and develop strategies to increase population immunity against SARS-CoV-2. Methods: In the framework of the nationwide, representative longitudinal CON-VINCE study, a sample of 1589 respondents (49.6% women, 84.3% Luxembourg nationality) ranging from 18-84 years, participated in the survey in spring 2021. The protocol of the CON-VINCE study has been described in detail elsewhere (Snoeck et al. 2020). Results: 52% of the respondents had at least partial vaccination at time of assessment between April to June 2021. The most common reasons for vaccination of those willing to be vaccinated (81.2%) were altruistic motivations. Prevalent reasons against vaccination for those undecided (8.7%) or reluctant (10.2%) to be vaccinated were that the vaccine had not been tested sufficiently and the fear of long-term vaccine side effects. Only very few of the vaccination-hesitant or -reluctant respondents reported that they did not believe in vaccination in general. Conclusion: The present study identified motivations for and against COVID-19 vaccination and determined demographic and socio-economic factors associated with vaccination willingness. To increase vaccination rates, public health communication needs to target those unsure or unwilling to be vaccinated. We will continue to study the vaccination uptake in the Luxembourg population, as CON-VINCE is now part of the H2020-funded international ORCHESTRA project (https://orchestra-cohort.eu), research into comparing these results on a Pan-European level. [less ▲]

Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?

in Drug Discovery Today (2022)

Despite the intuitive value of adopting the Findable, Accessible, Interoperable, and Reusable (FAIR) principles in both academic and industrial sectors, challenges exist in resourcing, balancing long ... [more ▼]

Despite the intuitive value of adopting the Findable, Accessible, Interoperable, and Reusable (FAIR) principles in both academic and industrial sectors, challenges exist in resourcing, balancing long- versus short-term priorities, and achieving technical implementation. This situation is exacerbated by the unclear mechanisms by which costs and benefits can be assessed when decisions on FAIR are made. Scientific and research and development (R&D) leadership need reliable evidence of the potential benefits and information on effective implementation mechanisms and remediating strategies. In this article, we describe procedures for cost–benefit evaluation, and identify best-practice approaches to support the decision-making process involved in FAIR implementation. [less ▲]

Translational Challenges of Biomedical Machine Learning Solutions in Clinical and Laboratory Settings

in Bioinformatics and Biomedical Engineering (2022)

The ever increasing use of artificial intelligence (AI) methods in biomedical sciences calls for closer inter-disciplinary collaborations that transfer the domain knowledge from life scientists to ... [more ▼]

The ever increasing use of artificial intelligence (AI) methods in biomedical sciences calls for closer inter-disciplinary collaborations that transfer the domain knowledge from life scientists to computer science researchers and vice-versa. We highlight two general areas where the use of AI-based solutions designed for clinical and laboratory settings has proven problematic. These are used to demonstrate common sources of translational challenges that often stem from the differences in data interpretation between the clinical and research view, and the unmatched expectations and requirements on the result quality metrics. We outline how explicit interpretable inference reporting might be used as a guide to overcome such translational challenges. We conclude with several recommendations for safer translation of machine learning solutions into real-world settings. [less ▲]

COBREXA.jl: constraint-based reconstruction and exascale analysis

in Bioinformatics (2021)

COBREXA.jl is a Julia package for scalable, high-performance constraint-based reconstruction and analysis of very large-scale biological models. Its primary purpose is to facilitate the integration of ... [more ▼]

COBREXA.jl is a Julia package for scalable, high-performance constraint-based reconstruction and analysis of very large-scale biological models. Its primary purpose is to facilitate the integration of modern high performance computing environments with the processing and analysis of large-scale metabolic models of challenging complexity. We report the architecture of the package, and demonstrate how the design promotes analysis scalability on several use-cases with multi-organism community models.https://doi.org/10.17881/ZKCR-BT30.Supplementary data are available at Bioinformatics online. [less ▲]

Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129

in Cardiovascular Research (2021)

The coronavirus disease 2019 (COVID-19) pandemic has been as unprecedented as unexpected, affecting more than 105 million people worldwide as of 8 February 2020 and causing more than 2.3 million deaths ... [more ▼]

The coronavirus disease 2019 (COVID-19) pandemic has been as unprecedented as unexpected, affecting more than 105 million people worldwide as of 8 February 2020 and causing more than 2.3 million deaths according to the World Health Organization (WHO). Not only affecting the lungs but also provoking acute respiratory distress, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is able to infect multiple cell types including cardiac and vascular cells. Hence a significant proportion of infected patients develop cardiac events, such as arrhythmias and heart failure. Patients with cardiovascular comorbidities are at highest risk of cardiac death. To face the pandemic and limit its burden, health authorities have launched several fast-track calls for research projects aiming to develop rapid strategies to combat the disease, as well as longer-term projects to prepare for the future. Biomarkers have the possibility to aid in clinical decision-making and tailoring healthcare in order to improve patient quality of life. The biomarker potential of circulating RNAs has been recognized in several disease conditions, including cardiovascular disease. RNA biomarkers may be useful in the current COVID-19 situation. The discovery, validation, and marketing of novel biomarkers, including RNA biomarkers, require multi-centre studies by large and interdisciplinary collaborative networks, involving both the academia and the industry. Here, members of the EU-CardioRNA COST Action CA17129 summarize the current knowledge about the strain that COVID-19 places on the cardiovascular system and discuss how RNA biomarkers can aid to limit this burden. They present the benefits and challenges of the discovery of novel RNA biomarkers, the need for networking efforts, and the added value of artificial intelligence to achieve reliable advances. [less ▲]

Proceedings of the AI4Health Lecture Series (2021)

Scientific Conference (2021)

The research field between Artificial Intelligence and Health sciences has established itself as a central research direction in recent years and has also further increased social interest. On the one ... [more ▼]

The research field between Artificial Intelligence and Health sciences has established itself as a central research direction in recent years and has also further increased social interest. On the one hand, this is due to the emergence of medical mass data and their use for AI-related fields, such as machine learning, human-computer interfaces and natural language-processing systems, and on the other hand, it is also due to the steadily growing social interest, which is not determined by the current Covid 19 pandemic. To this end, the lecture series is intended to provide an opportunity for scientific exchange. [less ▲]

Supporting findability of COVID-19 research with large-scale text mining of scientific publications

Poster (2020, November 27)

When the COVID-19 pandemic hit in early 2020, a lot of research efforts were quickly redirected towards studies on SARS-CoV2 and COVID-19 disease, from the sequencing and assembly of viral genomes to the ... [more ▼]

When the COVID-19 pandemic hit in early 2020, a lot of research efforts were quickly redirected towards studies on SARS-CoV2 and COVID-19 disease, from the sequencing and assembly of viral genomes to the elaboration of robust testing methodologies and the development of treatment and vaccination strategies. At the same time, a flurry of scientific publications around SARS-CoV-2 and COVID-19 began to appear, making it increasingly difficult for researchers to stay up-to-date with latest trends and developments in this rapidly evolving field. The BioKB platform is a pipeline which, by exploiting text mining and semantic technologies, helps researchers easily access semantic content of thousands of abstracts and full text articles. The content of the articles is analysed and concepts from a range of contexts, including proteins, species, chemicals, diseases and biological processes are tagged based on existing dictionaries of controlled terms. Co-occurring concepts are classified based on their asserted relationship and the resulting subject-relation-object triples are stored in a publicly accessible human- and machine-readable knowledge base. All concepts in the BioKB dictionaries are linked to stable, persistent identifiers, either a resource accession such as an Ensembl, Uniprot or PubChem ID for genes, proteins and chemicals, or an ontology term ID for diseases, phenotypes and other ontology terms. In order to improve COVID-19 related text mining, we extended the underlying dictionaries to include many additional viral species (via NCBI Taxonomy identifiers), phenotypes from the Human Phenotype Ontology (HPO), COVID-related concepts including clinical and laboratory tests from the COVID-19 ontology, as well as additional diseases (DO) and biological processes (GO). We also added all viral proteins found in UniProt and gene entries from EntrezGene to increase the sensitivity of the text mining pipeline to viral data. To date, BioKB has indexed over 270’000 sentences from 21’935 publications relating to coronavirus infections, with publications dating from 1963 to 2021, 3’863 of which were published this year. We are currently working to further refine the text mining pipeline by training it on the extraction of increasingly complex relations such as protein-phenotype relationships. We are also regularly adding new terms to our dictionaries for areas where coverage is currently low, such as clinical and laboratory tests and procedures and novel drug treatments. [less ▲]

BioKC: a platform for quality controlled curation and annotation of systems biology models

Scientific Conference (2020, September 04)

Standardisation of biomedical knowledge into systems biology models is essential for the study of the biological function. However, biomedical knowledge curation is a laborious manual process aggravated ... [more ▼]

Standardisation of biomedical knowledge into systems biology models is essential for the study of the biological function. However, biomedical knowledge curation is a laborious manual process aggravated by the ever increasing growth of biomedical literature. High quality curation currently relies on pathway databases where outsider participation is minimal. The increasing demand of systems biology knowledge presents new challenges regarding curation, calling for new collaborative functionalities to improve quality control of the review process. These features are missing in the current systems biology environment, whose tools are not well suited for an open community-based model curation workflow. On one hand, diagram editors such as CellDesigner or Newt provide limited annotation features. On the other hand, most popular text annotations tools are not aimed for biomedical text annotation or model curation. Detaching the model curation and annotation tasks from diagram editing improves model iteration and centralizes the annotation of such models with supporting evidence. In this vain, we present BioKC, a web-based platform for systematic quality-controlled collaborative curation and annotation of biomedical knowledge following the standard data model from Systems Biology Markup Language (SBML). [less ▲]

Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.

E-print/Working paper (2020)

BACKGROUND: After the World Health Organization declared the outbreak of coronavirus disease to be a public health emergency of international concern on January 30, 2020, the first SARS-CoV-2 infection ... [more ▼]

BACKGROUND: After the World Health Organization declared the outbreak of coronavirus disease to be a public health emergency of international concern on January 30, 2020, the first SARS-CoV-2 infection was detected in Luxembourg on February 29, 2020. Representative population-based data, including asymptomatic individuals for assessing the viral spread and immune response were, however, lacking worldwide. METHODS: Using a panel-based method, we implemented a representative sample of the Luxembourgish population based on age, gender and residency for testing for SARS-CoV-2 infection and antibody status in order to define prevalence irrespective of clinical symptoms. Participants were contacted via email to fill an online questionnaire before biosampling at local laboratories. All participants provided information related to clinical symptoms, epidemiology, socioeconomic and psychological assessments and underwent biosampling, rRT-PCR testing and serology for SARS-CoV-2. RESULTS: We included a total of 1862 individuals in our representative sample of the general Luxembourgish population. Of these, 5 individuals had a current positive result for infection with SARS-CoV-2 based on rRT-PCR. Four of these individuals were oligosymptomatic and one was asymptomatic. Overall we found a positive IgG antibody status in 35 individuals (1.97%), of which 11 reported to be tested positive by rRT-PCR for SARS-CoV-2 previously and showed in addition their IgG positive status also a positive status for IgA. Our data indicate a prevalence of 0.3% for active SARS-CoV-2 infection and an infection rate of 2.15% in the Luxembourgish population between 18 and 79 years of age. CONCLUSIONS: Luxembourgish residents show a low rate of acute infections after 7 weeks of confinement and present with an antibody profile indicative of a more recent immune response to SARS-CoV-2. All infected individuals were oligo- or asymptomatic. Bi-weekly follow-up visits over the next 2 months will inform about the viral spread by a- and oligosymptomatic carriers and the individual changes in the immune profile.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04379297Funding StatementThe CON-VINCE Study is funded by the Research Fund Luxembourg (FNR; CON-VINCE) and the André Losch Foundation (Luxembourg).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to ethical concerns, supporting data cannot be made openly available. [less ▲]